J. Safra Sarasin Holding Ag Abb Vie Inc. Transaction History
J. Safra Sarasin Holding Ag
- $5.79 Trillion
- Q2 2025
A detailed history of J. Safra Sarasin Holding Ag transactions in Abb Vie Inc. stock. As of the latest transaction made, J. Safra Sarasin Holding Ag holds 284,751 shares of ABBV stock, worth $56.6 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
284,751
Previous 135,373
110.35%
Holding current value
$56.6 Million
Previous $28.3 Billion
86.47%
% of portfolio
0.91%
Previous 0.51%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,255Shares Held
1.28BCall Options Held
16.1MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA177MShares$35.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.17 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $351B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...